These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37758949)

  • 21. Rearrangements in the relative orientation of cytoplasmic domains induced by a membrane-anchored protein mediate modulations in Kv channel gating.
    Lvov A; Greitzer D; Berlin S; Chikvashvili D; Tsuk S; Lotan I; Michaelevski I
    J Biol Chem; 2009 Oct; 284(41):28276-28291. PubMed ID: 19690160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carvedilol blockage of delayed rectifier Kv2.1 channels and its molecular basis.
    Cheng N; Ren S; Yang JF; Liu XM; Li XT
    Eur J Pharmacol; 2019 Jul; 855():50-55. PubMed ID: 31063774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the interaction of tarantula toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the voltage sensor of Kv2.1 uncovers the molecular basis for cross-activities on Kv2.1 and Nav1.5 channels.
    Tao H; Chen JJ; Xiao YC; Wu YY; Su HB; Li D; Wang HY; Deng MC; Wang MC; Liu ZH; Liang SP
    Biochemistry; 2013 Oct; 52(42):7439-48. PubMed ID: 24044413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of the Kv2.1 delayed rectifier potassium channel leads to neuronal and behavioral hyperexcitability.
    Speca DJ; Ogata G; Mandikian D; Bishop HI; Wiler SW; Eum K; Wenzel HJ; Doisy ET; Matt L; Campi KL; Golub MS; Nerbonne JM; Hell JW; Trainor BC; Sack JT; Schwartzkroin PA; Trimmer JS
    Genes Brain Behav; 2014 Apr; 13(4):394-408. PubMed ID: 24494598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells.
    Yuan XJ; Wang J; Juhaszova M; Golovina VA; Rubin LJ
    Am J Physiol; 1998 Apr; 274(4):L621-35. PubMed ID: 9575881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of ion channel localization and phosphorylation by neuronal activity.
    Misonou H; Mohapatra DP; Park EW; Leung V; Zhen D; Misonou K; Anderson AE; Trimmer JS
    Nat Neurosci; 2004 Jul; 7(7):711-8. PubMed ID: 15195093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The C-terminus of neuronal Kv2.1 channels is required for channel localization and targeting but not for NMDA-receptor-mediated regulation of channel function.
    Baver SB; O'Connell KM
    Neuroscience; 2012 Aug; 217():56-66. PubMed ID: 22554782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation-dependent regulation of Kv2.1 Channel activity at tyrosine 124 by Src and by protein-tyrosine phosphatase epsilon.
    Tiran Z; Peretz A; Attali B; Elson A
    J Biol Chem; 2003 May; 278(19):17509-14. PubMed ID: 12615930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A KV2.1 gating modifier binding assay suitable for high throughput screening.
    Schmalhofer WA; Ratliff KS; Weinglass A; Kaczorowski GJ; Garcia ML; Herrington J
    Channels (Austin); 2009 Nov; 3(6):437-47. PubMed ID: 21150283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voltage sensitivity and gating charge in Shaker and Shab family potassium channels.
    Islas LD; Sigworth FJ
    J Gen Physiol; 1999 Nov; 114(5):723-42. PubMed ID: 10539976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium- and metabolic state-dependent modulation of the voltage-dependent Kv2.1 channel regulates neuronal excitability in response to ischemia.
    Misonou H; Mohapatra DP; Menegola M; Trimmer JS
    J Neurosci; 2005 Nov; 25(48):11184-93. PubMed ID: 16319318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of Kv2.1 channel gating and TEA sensitivity by distinct domains of SNAP-25.
    He Y; Kang Y; Leung YM; Xia F; Gao X; Xie H; Gaisano HY; Tsushima RG
    Biochem J; 2006 Jun; 396(2):363-9. PubMed ID: 16478442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant.
    Hawkins NA; Misra SN; Jurado M; Kang SK; Vierra NC; Nguyen K; Wren L; George AL; Trimmer JS; Kearney JA
    Neurobiol Dis; 2021 Jan; 147():105141. PubMed ID: 33132203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independent movement of the voltage sensors in K
    Bocksteins E; Snyders DJ; Holmgren M
    Sci Rep; 2017 Jan; 7():41646. PubMed ID: 28139741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct interaction of target SNAREs with the Kv2.1 channel. Modal regulation of channel activation and inactivation gating.
    Michaelevski I; Chikvashvili D; Tsuk S; Singer-Lahat D; Kang Y; Linial M; Gaisano HY; Fili O; Lotan I
    J Biol Chem; 2003 Sep; 278(36):34320-30. PubMed ID: 12807875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heteromeric K
    Gayet-Primo J; Yaeger DB; Khanjian RA; Puthussery T
    J Neurosci; 2018 Apr; 38(14):3414-3427. PubMed ID: 29483285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target soluble N-ethylmaleimide-sensitive factor attachment protein receptors (t-SNAREs) differently regulate activation and inactivation gating of Kv2.2 and Kv2.1: Implications on pancreatic islet cell Kv channels.
    Wolf-Goldberg T; Michaelevski I; Sheu L; Gaisano HY; Chikvashvili D; Lotan I
    Mol Pharmacol; 2006 Sep; 70(3):818-28. PubMed ID: 16754785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the voltage-gated potassium channel Kv2.1 by the anti-tumor alkylphospholipid perifosine.
    Delgado-Ramírez M; Morán-Zendejas R; Aréchiga-Figueroa IA; Toro-Castillo C; Ramírez-Martínez JF; Rodríguez-Menchaca AA
    Pharmacol Rep; 2016 Apr; 68(2):457-61. PubMed ID: 26922553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct modifications in Kv2.1 channel via chemokine receptor CXCR4 regulate neuronal survival-death dynamics.
    Shepherd AJ; Loo L; Gupte RP; Mickle AD; Mohapatra DP
    J Neurosci; 2012 Dec; 32(49):17725-39. PubMed ID: 23223293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of Kv2.1 channels inactivation by curcumin.
    Aréchiga-Figueroa IA; Delgado-Ramírez M; Morán-Zendejas R; Rodríguez-Menchaca AA
    Pharmacol Rep; 2015 Dec; 67(6):1273-9. PubMed ID: 26481552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.